Koho Iizuka

3.3k total citations · 1 hit paper
41 papers, 2.7k citations indexed

About

Koho Iizuka is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Koho Iizuka has authored 41 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Immunology, 17 papers in Oncology and 9 papers in Molecular Biology. Recurrent topics in Koho Iizuka's work include Immune Cell Function and Interaction (15 papers), T-cell and B-cell Immunology (11 papers) and CAR-T cell therapy research (7 papers). Koho Iizuka is often cited by papers focused on Immune Cell Function and Interaction (15 papers), T-cell and B-cell Immunology (11 papers) and CAR-T cell therapy research (7 papers). Koho Iizuka collaborates with scholars based in United States, Japan and Australia. Koho Iizuka's co-authors include Wayne M. Yokoyama, Sung‐Jin Kim, Daved H. Fremont, Olga V. Naidenko, Anthony R. French, Ayotunde O. Dokun, Suellen Greco, Héctor L. Aguila, Irving L. Weissman and Hiroshi Furukawa and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

Koho Iizuka

38 papers receiving 2.7k citations

Hit Papers

Recognition of a virus-encoded ligand by a natural killer... 2002 2026 2010 2018 2002 200 400 600

Peers

Koho Iizuka
Linda Diehl Germany
Joonsoo Kang United States
Scott B. Lovitch United States
Carmela De Santo United Kingdom
Linda Diehl Germany
Koho Iizuka
Citations per year, relative to Koho Iizuka Koho Iizuka (= 1×) peers Linda Diehl

Countries citing papers authored by Koho Iizuka

Since Specialization
Citations

This map shows the geographic impact of Koho Iizuka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Koho Iizuka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Koho Iizuka more than expected).

Fields of papers citing papers by Koho Iizuka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Koho Iizuka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Koho Iizuka. The network helps show where Koho Iizuka may publish in the future.

Co-authorship network of co-authors of Koho Iizuka

This figure shows the co-authorship network connecting the top 25 collaborators of Koho Iizuka. A scholar is included among the top collaborators of Koho Iizuka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Koho Iizuka. Koho Iizuka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
3.
Liu, Stephen V., D. Ross Camidge, Scott Gettinger, et al.. (2018). Long-term survival follow-up of atezolizumab in combination with platinum-based doublet chemotherapy in patients with advanced non–small-cell lung cancer. European Journal of Cancer. 101. 114–122. 38 indexed citations
4.
Liu, Stephen V., D. Ross Camidge, Scott Gettinger, et al.. (2017). Atezolizumab (atezo) plus platinum-based chemotherapy (chemo) in non-small cell lung cancer (NSCLC): Update from a phase Ib study.. Journal of Clinical Oncology. 35(15_suppl). 9092–9092. 24 indexed citations
5.
Suzuki, Kenshi, Michinori Ogura, Yu Abe, et al.. (2015). Phase 1 study in Japan of siltuximab, an anti-IL-6 monoclonal antibody, in relapsed/refractory multiple myeloma. International Journal of Hematology. 101(3). 286–294. 24 indexed citations
6.
Ito, Daisuke, et al.. (2009). Essential role of the Ly49A stalk region for immunological synapse formation and signaling. Proceedings of the National Academy of Sciences. 106(27). 11264–11269. 11 indexed citations
7.
Somia, Nikunj V., et al.. (2009). Identification of NK Cell Receptor Ligands Using a Signaling Reporter System. Methods in molecular biology. 612. 285–297. 6 indexed citations
8.
Kim, Sung‐Jin, Darryl A. Higuchi, Hyunseok P. Kang, et al.. (2005). Arrested natural killer cell development associated with transgene insertion into the Atf2 locus. Blood. 107(3). 1024–1030. 18 indexed citations
9.
Iizuka, Koho, Olga V. Naidenko, Béatrice Plougastel-Douglas, Daved H. Fremont, & Wayne M. Yokoyama. (2003). Genetically linked C-type lectin-related ligands for the NKRP1 family of natural killer cell receptors. Nature Immunology. 4(8). 801–807. 232 indexed citations
10.
Smith, Hamish R.C., Jonathan W. Heusel, Sung‐Jin Kim, et al.. (2002). Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proceedings of the National Academy of Sciences. 99(13). 8826–8831. 615 indexed citations breakdown →
11.
Furukawa, Hiroshi, Koho Iizuka, Jennifer Poursine‐Laurent, Nilabh Shastri, & Wayne M. Yokoyama. (2002). A Ligand for the Murine NK Activation Receptor Ly-49D: Activation of Tolerized NK Cells from β2-Microglobulin- Deficient Mice. The Journal of Immunology. 169(1). 126–136. 49 indexed citations
12.
Kim, Sung‐Jin, Koho Iizuka, Ayotunde O. Dokun, et al.. (2002). In vivo developmental stages in murine natural killer cell maturation. Nature Immunology. 3(6). 523–528. 486 indexed citations
13.
Takahashi, Shinji, Kaori Takagi, Takaichi Miwa, et al.. (1999). Pharmacological profile of MS-377, a novel antipsychotic agent with selective affinity for σ receptors. Psychopharmacology. 145(3). 295–302. 33 indexed citations
14.
Iizuka, Koho, David Chaplin, Yang Wang, et al.. (1999). Requirement for membrane lymphotoxin in natural killer cell development. Proceedings of the National Academy of Sciences. 96(11). 6336–6340. 105 indexed citations
15.
Kaneko, Hideo, Nobutaka Kiyokawa, Koho Iizuka, et al.. (1996). Lack of CD54 Expression and Mutation of p53 Gene Relate to the Prognosis of Childhood Burkitt's Lymphoma. Leukemia & lymphoma. 21(5-6). 449–455. 8 indexed citations
17.
Kaneko, Hiroki, Koho Iizuka, Y Kokai, et al.. (1995). Vaccination with a synthetic T-cell receptor V-region peptide: immunomodulation or vaccination.. PubMed. 27(2). 1539–42.
18.
Iizuka, Koho, Tetsuhide Kamijo, Hitoshi Harada, et al.. (1990). Synthesis and structure-activity relationships of human renin inhibitors designed from angiotensinogen transition state.. Chemical and Pharmaceutical Bulletin. 38(9). 2487–2493. 11 indexed citations
19.
Wakitani, K., Nobuo Katsube, A Kawasaki, et al.. (1983). Pharmacological studies on OKY-1581: a selective thromboxane synthetase inhibitor.. PubMed. 11. 241–4. 8 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026